Compare SaaS Products

Anara helps researchers understand, organize and write scientific documents, together. We started working on Anara 18 months ago. In that time: - we’ve grown to 2M users spanning hundreds of major colleges and research-led companies, - we reached $3M in yearly revenue and are fast approaching $4M, - 200M+ people have seen our content across Instagram, TikTok and YouTube, - and we raised $2.4M from YC and the founders of Github and Reddit. Looking ahead, we’re expanding beyond summarization and writing assistance to address the broader challenges of information overload faced by academics and research teams. We're a small, tight-knit team with huge ambitions and we’re hiring across design, engineering and growth. As a founding member of the team, you'll be instrumental in helping us scale revenue from $3M to $10M and then $10M to $100M+. If you’re excited by the idea of being a part of that, definitely reach out.

Angstrom AI builds GenAI-based molecular simulations to substitute wet lab experiments in the pre-clinical drug development pipeline. We are a team of 2 PhD's and 2 Professors from the University of Cambridge who decided to start a company together after we realised how to combine breakthoughs in our research in quantum-accurate models of physics and generative AI models. Our Biotech/Pharma clients can verify the efficacy and safety of new drug candidates using our computer simulations, which match the accuracy of wet lab experiments, but are over 100x faster. We achieve this accuracy by constraining our genAI-based simulations to obey the laws of physics, avoiding the hallucinations seen in other GenAI technologies. Since joining YC, Angstrom AI has developed the first physically accurate gen-AI based simulation of multiple molecules interacting. We have published the first molecule water solubility results with accuracy within the error range of wet lab experiments. We have also kicked-off a 150K pilot project with a pharma company to apply our tech to estimating solubility in their drug development pipeline.